日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint

尼洛替尼与伊马替尼的比较,以及早期从伊马替尼转换为尼洛替尼治疗在初诊慢性粒细胞白血病患者中实现无治疗缓解的疗效:首个共同主要终点的分析

Castagnetti, Fausto; Breccia, Massimo; Abruzzese, Elisabetta; Bassan, Renato; Binotto, Gianni; Bonifacio, Massimiliano; Caocci, Giovanni; Capodanno, Isabella; Cavazzini, Francesco; Cimino, Giuseppe; Fazi, Paola; Gozzini, Antonella; Iurlo, Alessandra; Janssen, Jeroen J W M; Lunghi, Monia; Marasca, Roberto; Martino, Bruno; Messina, Monica; Muriano, Francesco; Paoloni, Francesca; Piciocchi, Alfonso; Rosti, Gianantonio; Russo Rossi, Antonella; Saglio, Giuseppe; Sica, Simona; Soverini, Simona; Tafuri, Agostino; Vallisa, Daniele; Westerweel, Peter E; Pane, Fabrizio

Interim analysis of a multicenter study on patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: the RODEO study

慢性粒细胞白血病患者指导下酪氨酸激酶抑制剂剂量减少的多中心研究的中期分析:RODEO 研究

Lokhorst, Dina Nienke; Smit, Yolba; Van den Bemt, Bart J F; Hermens, Rosella P M G; Nijziel, Marten R; Jie, Asiong K-S; Daenen, Laura G M; Klein, Saskia K; Posthuma, Eduardus F M; Westerweel, Peter E; Donker, Marjolein; Hoogendoorn, Mels; Bekker, Charlotte L; Blijlevens, Nicole M A

Pharmacological boosting of azacitidine/venetoclax in acute myeloid leukemia

药物增强阿扎胞苷/维奈托克在急性髓系白血病中的疗效

Westra, Niels; Cerro, Elena Ropero; Schilder, Edwin; Lub-de Hooge, Marjolijn N; Touw, Daan J; Kosterink, Jos G W; Chitu, Dana A; Ammatuna, Emanuele; Klein, Saskia K; Westerweel, Peter E; Cuijpers, Marloes; Cruijsen, Marjan; Corsten, Maarten M F; Alhan, Canan; Tick, Lidwine; Schuringa, Jan Jacob; Huls, Gerwin; Woolthuis, Carolien M; Oude Munnink, Thijs H

Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients

奥妥珠单抗联合维奈克拉治疗可重塑慢性淋巴细胞白血病患者的治疗反应谱

Hengeveld, Paul J; Schilperoord-Vermeulen, Joyce; Kolijn, P Martijn; Dubois, Julie M N; Westerweel, Peter E; Kersting, Sabina; Kater, Arnon P; Levin, Mark-David; Langerak, Anton W

The prognostic value of health-related quality of life for early molecular response in patients with chronic myeloid leukemia: analysis of the GIMEMA-SUSTRENIM trial

健康相关生活质量对慢性粒细胞白血病患者早期分子反应的预后价值:GIMEMA-SUSTRENIM试验分析

Efficace, Fabio; Cannella, Laura; Capodanno, Isabella; Sancetta, Rosaria; Porcu, Veronica; Lunghi, Monia; Biagi, Annalisa; Castagnetti, Fausto; Caocci, Giovanni; Baldi, Thomas; Marasca, Roberto; Bonifacio, Massimiliano; Gozzini, Antonella; Martino, Bruno; Sora, Federica; Westerweel, Peter E; Fazi, Paola; Vignetti, Marco; Pane, Fabrizio; Breccia, Massimo

Sustained treatment-free remission in two chronic myeloid leukemia patients after asciminib discontinuation: a report of two cases

两例慢性粒细胞白血病患者停用阿西米尼后持续无治疗缓解:两例病例报告

Yousefi, Arjen; Levin, Mark-David; Cornelissen, Jan J; Westerweel, Peter E

Midostaurin added to 10-day decitabine, for patients unfit for intensive chemotherapy with AML and higher risk MDS, irrespective of FLT3 mutational status, does not improve outcome

对于不适合接受强化化疗的急性髓系白血病 (AML) 和高危骨髓增生异常综合征 (MDS) 患者,无论 FLT3 突变状态如何,在 10 天地西他滨疗程中加入米哚妥林并不能改善预后。

Huls, Gerwin; Chitu, Dana A; Tick, Lidwine; Boersma, Rinske; Breems, Dimitri; Herbers, Alexandra; Klein, Saskia K; de Jonge, Suzan; Westerweel, Peter E; Cruijsen, Marjan; Hoogendoorn, Mels; Cuijpers, Marlous; Deeren, Dries; Bailly, Benjamin; Visser, Otto; van Rhenen, Anna; Posthuma, Eduard F M; Valk, Peter J M; Cloos, Jacqueline; Ammatuna, Emanuele; Refos, Jeannine M; Fakkert, R; Löwenberg, Bob; Ossenkoppele, Gert J

Heavy menstrual bleeding on direct factor Xa inhibitors: the MEDEA randomized clinical trial

直接Xa因子抑制剂引起的月经过多:MEDEA随机临床试验

Hamulyák, Eva N; Wiegers, Hanke M G; Hutten, Barbara A; de Lange, Maria E; Timmermans, Anne; Westerweel, Peter E; Nijziel, Marten R; Klok, Frederikus A; Hovens, Marcel M; Kamphuisen, Pieter W; Büller, Harry R; Middeldorp, Saskia; Scheres, Luuk J J

Varying concentrations of tyrosine kinase inhibitors in chronic myeloid leukemia patients following bariatric surgery: a case series

慢性粒细胞白血病患者接受减肥手术后酪氨酸激酶抑制剂浓度的变化:病例系列研究

Lau, Cedric; van Kesteren, Charlotte; Cao, Yong Xin; Smeenk, Robert M; Daenen, Laura G M; Janssen, Jeroen J W M; Westerweel, Peter E

High-throughput Proteomics Identifies THEMIS2 as Independent Biomarker of Treatment-free Survival in Untreated CLL

高通量蛋白质组学鉴定出THEMIS2是未经治疗的慢性淋巴细胞白血病患者无治疗生存期的独立生物标志物

Hengeveld, Paul J; Kolijn, P Martijn; Demmers, Jeroen A A; Doff, Wouter; Dubois, Julie M N; Rijken, Melissa; Assmann, Jorn L J C; van der Straten, Lina; Boiten, Henk Jan; Gussinklo, Kirsten J; Valk, Peter J M; Faber, Laura M; Westerweel, Peter E; Kater, Arnon P; Levin, Mark-David; Langerak, Anton W